Blog articles for PHASE Scientific USA
Every household has a person with the job description of “chief medical officer.” While not an official title, the job involves researching and deciding the best healthcare action for the family. There is an excellent chance this person is not a healthcare professional and, in most households, is a woman. According […]
(GARDEN GROVE, CA,) – April 18th, 2023 – PHASE Scientific Americas, a fast-growing biotechnology company, announces that its successful at-home rapid molecular INDICAID® COVID-19 Rapid Antigen At-Home Test now recognizes the new […]
March 23, 2023
The pandemic accelerated transformation in nursing and diagnostics. One result? The healthcare sector needs to better train the next generation of nurses on how to use new diagnostic technologies and how to counsel patients on the tests and findings. Health educators have taken note…and action.
Through […]
February 27, 2023
Achieving health equity, in which everyone has a fair and just opportunity to attain their highest level of health, requires ongoing efforts to address historical and contemporary injustices, overcome barriers to healthcare access, and eliminate preventable health disparities. When it comes to diagnostics, the COVID-19 pandemic cast a harsh […]
February 20, 2023
The federal COVID-19 Test-to-Treat program launched in March 2022 but the test-to-treat response to infectious disease isn’t new. It does need renewal, however.
Test-to-treat describes an early intervention approach to infectious disease in which a patient gets tested as soon as possible and, if positive, promptly receives an appropriate treatment. […]
November 21, 2022
Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen Test.
An independent evaluation by the National Institutes of Health (NIH) RADx Variant Task Force has determined that the INDICAID® test detects the […]
While the recent surges of current COVID-19 variants are not driving high levels of hospitalization and death, the persistent, circulating virus continues to affect employees and spike absenteeism across businesses of all sizes. The impact is serious, affecting not only day-to-day operations and productivity […]
A virus that shows no signs of disappearing, variants that are adept at dodging the body’s defenses, and waves of infections two, maybe three times a year — this may be the future of Covid-19, some scientists now […]
Packed indoor events and fully booked flights where masks are few and far between suggest that the pandemic is a distant, unpleasant memory.
In reality, Covid-19 cases have steadily increased nationwide since the end of March. […]
April 04, 2022
Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen test. A sub-variant of Omicron designated BA.2 (B.1.1529.2) was detected in the U.S. in January 2022, and the Centers […]
